Ajanta Pharma Limited — Important, 05-02-2025: Updates

The Nomination and Remuneration Committee of Ajanta Pharma has granted 13,000 cash-settled Stock Appreciation Rights (SARs) under its Share Based Incentive Plan 2019. The SARs have a vesting period of one year from the grant date, which is set for January 30, 2025. This move reflects the company’s ongoing commitment to aligning employee rewards with shareholder value, potentially enhancing motivation and retention. Investors may view this as a positive step toward promoting long-term growth and employee engagement.